1. Canada Stocks

  2. •

    Technology

  3. •

    Software - Application
CardioComm Solutions, Inc.

CardioComm Solutions, Inc.

EKG.V
CardioComm Solutions, Inc.CA flagToronto Stock Exchange Ventures
0.01
CAD
- -
- -
1.98MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
- -
0.01
0.01
- -
- -
- -
Basic EPS, GAAP
-0.02
-0.01
-0.01
- -
- -
- -
-0.01
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
-0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.01
-0.01
- -
- -
- -
-0.01
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
-0.01
-0.01
- -
- -
- -
-0.01
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
100
107
112
116
135
137
140
141
149
151
151
171
195
194
Sales/Revenue/Turnover
2
2
2
2
2
1
1
1
1
1
1
1
- -
- -
Operating Margin (%)
-101.88
-64.33
-36.24
2.12
9.29
-46.8
-44.44
-9.34
-31.42
-7.41
-23.51
-49.59
-204.71
-204.71
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-2
-1
-1
- -
- -
-1
-1
- -
- -
- -
- -
- -
-1
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-100.45
-63.45
-34.76
-1.48
2.28
-53.65
-121.4
-7.62
0.04
-0.25
-11.11
-36.94
-194.55
-186.97
Working Capital
- -
-1
-1
- -
- -
- -
-1
-1
- -
- -
-1
- -
-1
-1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
-1
-1
- -
- -
- -
-1
-1
- -
- -
-1
- -
-1
-1
Return on Invested Capital (%)
- -
- -
- -
- -
18.87
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
12.3
- -
- -
- -
-17.15
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
193
197
198
Market Capitalization
2
2
2

Working Capital

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
- -
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-536.24%
17.47%
149.27%
Free Cash Flow
-80.68%
-117.95%
293.89%
Net Income, GAAP
113.37%
613.7%
172.12%
Sales/Revenue/Turnover
-13.2%
-14.51%
-48.33%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1
2024
- -
- -
- -
- -
1
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Etienne Grima
Sector
Technology
Industry
Software - Application
Address
18 Wynford Drive Toronto ON Canada M3C 3S2
IPO Date
Jan 20, 1999
Website
cardiocommsolutions.com
Similar Companies
IMINT Image Intelligence AB (publ.) (IMNTF)
exactEarth Ltd. (XCT.TO)
Michpal Technologies Ltd. (MCPL.TA)
Ackroo Inc. (AKRFF)
Sap Se (SAPS.TO)
Imprivata, Inc. (IMPR)
Business
CardioComm Solutions, Inc. develops and sells electrocardiogram and ambulatory arrhythmia monitoring solutions for medical and consumer markets, with operations focused on remote patient monitoring, telemedicine and cardiac data management. Founded in 1989 and headquartered in North York, Ontario, Canada, the company offers proprietary software, hardware and services including GEMS™ Global ECG Management System software; GEMS™ mobile and Home platforms; GlobalCardio™ EMR software; HealthCheck™ personal ECG monitors; HeartCheck™ handheld ECG devices and related mobile applications; ambulatory long-term continuous monitoring and 14-day Holter solutions; ECG reading, analysis, reporting and dashboard services; core laboratory and SMART Monitoring services; and telephonic and wireless ECG event recording solutions. The company serves physicians, clinics, hospitals, clinical trial sponsors, commercial monitoring providers and consumers, and it markets its technologies in North America and through global distribution and commercialization partnerships. Recent strategic developments include a June 2026 collaboration and joint development and intellectual property agreement with Predictiv AI Inc. to pursue AI-enabled healthcare software, automated ECG and biosignal interpretation, predictive analytics and workflow optimization, as well as a May 2026 decision to adopt the Coordinated Blanket Order 51-933 pilot and move from quarterly to semi-annual reporting. The company also announced an insider loan facility to support development of its GEMS Flex and 14-day Holter/LTCM platform and completed a royalty agreement termination in connection with that financing, underscoring its recent operational and product expansion efforts.